Covenant Asset Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-6,484
Closed -$3.5M 168
2024
Q1
$3.5M Buy
6,484
+98
+2% +$53.6K 0.57% 46
2023
Q4
$3.54M Sell
6,386
-230
-3% -$108K 0.64% 43
2023
Q3
$2.89M Sell
6,616
-15
-0.2% -$7.48K 0.76% 44
2023
Q2
$3.33M Buy
6,631
+3,127
+89% +$1.5M 0.85% 44
2023
Q1
$1.75M Buy
3,504
+111
+3% +$53.1K 0.42% 74
2022
Q4
$1.38M Sell
3,393
-27
-0.8% -$10.5K 0.33% 87
2022
Q3
$1.11M Sell
3,420
-3,670
-52% -$1.35M 0.32% 83
2022
Q2
$2.49M Sell
7,090
-175
-2% -$71.4K 0.79% 46
2022
Q1
$3.97M Sell
7,265
-6
-0.1% -$3.16K 1.07% 27
2021
Q4
$4.79M Buy
7,271
+297
+4% +$186K 1.27% 23
2021
Q3
$4.34M Buy
6,974
+79
+1% +$53.1K 1.29% 22
2021
Q2
$4.36M Sell
6,895
-35
-0.5% -$19.3K 1.3% 23
2021
Q1
$3.39M Buy
6,930
+170
+3% +$85.2K 1.06% 33
2020
Q4
$3.38M Buy
6,760
+235
+4% +$105K 1.11% 28
2020
Q3
$2.56M Sell
6,525
-178
-3% -$65.8K 0.82% 33
2020
Q2
$2.21M Sell
6,703
-72
-1% -$20.8K 0.49% 46
2020
Q1
$1.64M Buy
6,775
+96
+1% +$25.1K 0.5% 47
2019
Q4
$1.74M Buy
6,679
+99
+2% +$26.1K 0.76% 48
2019
Q3
$1.79M Buy
6,580
+145
+2% +$40.3K 0.9% 41
2019
Q2
$1.77M Buy
6,435
+355
+6% +$87.5K 0.92% 39
2019
Q1
$1.36M Buy
+6,080
New +$1.26M 0.71% 50

Other funds holding IDXX

Covenant Asset Management's IDXX Position: Q2 2024 in Review

Covenant Asset Management sold out of Idexx Laboratories (IDXX) in Q2 2024, closing a stake of 6,484 shares — an estimated $3.5M sold.

Covenant Asset Management first reported a position in IDXX in Q1 2019 and held it in 21 quarters. The position peaked at $4.79M in Q4 2021. 1,109 funds tracked by Wall St. Rank hold IDXX as of Q2 2024.

  • Covenant Asset Management reported no remaining Idexx Laboratories position as of Q2 2024 after selling out during the quarter.
  • Covenant Asset Management sold 6,484 Idexx Laboratories shares in Q2 2024, an estimated $3.5M.
  • Covenant Asset Management first reported a position in Idexx Laboratories in Q1 2019 and held it in 21 quarters.
  • Covenant Asset Management's Idexx Laboratories position peaked at $4.79M in Q4 2021.
  • 1,109 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2024.

Based on Covenant Asset Management's 13F filing for Q2 2024, filed 2 Aug 2024.